Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMAD3 | P84022 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | RECQL | P46063 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GLB1 | P16278 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CTRC | Q99895 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29838717 | 1.00 | SMAD3 (0.35) | SMAD3ALDH1A1THRBRECQLTDP1 | |
| SCHEMBL29838734 | 1.00 | SMAD3 (0.35) | SMAD3ALDH1A1THRBRECQLTDP1 | |
| SCHEMBL29389278 | 0.85 | THRB (0.41) | SMAD3ALDH1A1THRBRECQLTDP1 | |
| SCHEMBL4593779 | 0.85 | THRB (0.41) | SMAD3ALDH1A1THRBRECQLTDP1 | |
| SCHEMBL29461682 | 0.83 | SMAD3 (0.40) | SMAD3ALDH1A1THRBRECQLTDP1 | |
| SCHEMBL235829 | 0.83 | SMAD3 (0.40) | SMAD3ALDH1A1THRBRECQLTDP1 | |
| SCHEMBL6843543 | 0.82 | HPGD (0.46) | SMAD3ALDH1A1THRBRECQLTDP1 | |
| Cyanide SCHEMBL6533545 | 0.81 | SMAD3 (0.38) | SMAD3ALDH1A1THRBRECQLTDP1 | |
| SCHEMBL126497 | 0.79 | THRB (0.40) | SMAD3ALDH1A1THRBRECQLTDP1 | |
| SCHEMBL6045753 | 0.77 | ALDH1A1 (0.47) | SMAD3ALDH1A1THRBRECQLTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220178934-A1 | SIGNALING CONJUGATES AND METHODS OF USE | VENTANA MED SYST INC (US) | 2022-06-09 | — | — | US | claimed |
| US-20200333349-A1 | SIGNALING CONJUGATES AND METHODS OF USE | VENTANA MED SYST INC (US) | 2020-10-22 | — | — | US | claimed |
| US-20200326345-A1 | SIGNALING CONJUGATES AND METHODS OF USE | VENTANA MED SYST INC (US) | 2020-10-15 | — | — | US | claimed |
| US-20200319193-A1 | SIGNALING CONJUGATES AND METHODS OF USE | VENTANA MED SYST INC (US) | 2020-10-08 | — | — | US | claimed |
| US-20200249238-A1 | SIGNALING CONJUGATES AND METHODS OF USE | VENTANA MED SYST INC (US) | 2020-08-06 | — | — | US | claimed |
| US-20190018018-A1 | SIGNALING CONJUGATES AND METHODS OF USE | VENTANA MED SYST INC (US) | 2019-01-17 | — | — | US | claimed |
| US-20180328932-A1 | SIGNALING CONJUGATES AND METHODS OF USE | VENTANA MED SYST INC (US) | 2018-11-15 | — | — | US | claimed |
| US-11906523-B2 | Signaling conjugates and methods of use | VENTANA MEDICAL SYSTEMS, INC. (US) | 2024-02-20 | — | — | US | disclosed |
| WO-2024006052-A1 | IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS AND METHODS FOR DIAGNOSING AND TREATING CANCER | AGILENT TECHNOLOGIES, INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| US-20230417752-A1 | IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS AND METHODS FOR DIAGNOSING AND TREATING CANCER | AGILENT TECHNOLOGIES, INC. | 2023-12-28 | — | — | US | disclosed |
| US-20230331865-A1 | ANTIBODIES FOR USE IN IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS TO DIAGNOSE CANCER | AGILENT TECHNOLOGIES, INC. | 2023-10-19 | — | — | US | disclosed |
| EP-4255932-A1 | ANTI-HUMAN CD10 ANTIBODIES FOR USE IN IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS TO DIAGNOSE CANCER | Agilent Technologies, Inc. (US) | 2023-10-11 | — | — | EP | disclosed |
| EP-4204451-A1 | ANTIBODIES FOR USE IN IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS TO DIAGNOSE CANCER | Agilent Technologies, Inc. (US) | 2023-07-05 | — | — | EP | disclosed |
| US-20140267672-A1 | DIGITALLY ENHANCED MICROSCOPY FOR MULTIPLEXED HISTOLOGY | VENTANA MEDICAL SYSTEMS, INC. | 2014-09-18 | — | — | US | disclosed |
| US-20130260379-A1 | SIGNALING CONJUGATES AND METHODS OF USE | VENTANA MEDICAL SYSTEMS, INC. (US) | 2013-10-03 | — | — | US | disclosed |
| WO-2013148498-A1 | SIGNALING CONJUGATES AND METHODS OF USE | VENTANA MEDICAL SYSTEMS, INC. (US) | 2013-10-03 | — | — | WO | disclosed |
| US-20070059316-A1 | Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted pdt agents | LIGHT SCIENCES ONCOLOGY, INC. | 2007-03-15 | — | — | US | disclosed |
| EP-1670512-A2 | SINGLET OXYGEN PHOTOSENSITIZERS ACTIVATED BY TARGET BINDING ENHANCING THE SELECTIVITY OF TARGETED PDT AGENTS | Light Sciences Corporation (US) | 2006-06-21 | — | — | EP | disclosed |
| US-20060067889-A1 | Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents | LIGHT SCIENCES CORPORATION (US) | 2006-03-30 | — | — | US | disclosed |
| WO-2005030254-A2 | CONJUGATES FOR PHOTODYNAMIC THERAPY | LIGHT SCIENCES CORPORATION (US) | 2005-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11906523-B2 | Signaling conjugates and methods of use | CABLES1, ILK, BCR | SMAD3 1210/4885ALDH1A1 1683/4885THRB 308/4885 |
| US-20060067889-A1 | Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents | PPOX, HMBS, ROS1 | SMAD3 4639/4885ALDH1A1 1528/4885THRB 3060/4885 |
| US-20070059316-A1 | Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted pdt agents | PPOX, HMBS, ROS1 | SMAD3 4639/4885ALDH1A1 1528/4885THRB 3060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.